On discontinuing treatment in schizophrenia: a clinical conundrum
Guardado en:
Autor principal: | Robin Emsley |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a247b7a7e0e04f64bf3f7c54984ea641 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
por: Jonne Lintunen, et al.
Publicado: (2021) -
Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development
por: Gregory P. Strauss, et al.
Publicado: (2021) -
Learning stable and predictive network-based patterns of schizophrenia and its clinical symptoms
por: Mina Gheiratmand, et al.
Publicado: (2017) -
Relationship of ventral striatum activation during effort discounting to clinical amotivation severity in schizophrenia
por: Greer E. Prettyman, et al.
Publicado: (2021) -
Unravelling socio-motor biomarkers in schizophrenia
por: Piotr Słowiński, et al.
Publicado: (2017)